Healthtech funding in H2 2011
European Healthtech startup funding raised during H2 2011.
In H2 2011, 25 European Healthtech companies closed 25 funding rounds and raised €223M in equity funding (excluding debt and grants), up 59.8% versus H2 2010. Switzerland led by capital raised, and KFW was the most active investor. Data as of 6 Nov 2026.
Equity funding
€223M
+59.8% vs H2 2010 · excl. debt & grants
Funding rounds
25
+13.6% vs H2 2010
Companies
25
Top country
Switzerland
Rank among sectors
#2
11.5% of sector funding
Top-10 round share
83.0%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2011 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €11M | 1 |
| Aug | €18M | 4 |
| Sep | €24M | 5 |
| Oct | €47M | 6 |
| Nov | €107M | 6 |
| Dec | €16M | 3 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2011 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2011 | |
|---|---|
| Switzerland | €92M |
| UK | €40M |
| Austria | €33M |
| Germany | €17M |
| France | €15M |
| Denmark | €14M |
| Ireland | €6.1M |
| Spain | €3.5M |
Stage mix
by € raisedHealthtech — stage mix, H2 2011 — interactive chart.
Data table
| Healthtech — stage mix, H2 2011 | |
|---|---|
| Series C | €71M |
| Growth/Late | €43M |
| Early VC | €28M |
| Other | €26M |
| Series A | €23M |
| Series B | €18M |
| Series D+ | €13M |
| Seed | €931k |
Exits & M&A
1 Acquisition · 1 Buyout2 exits · €41M disclosed.
| Advanced Accelerator Applications | Buyout | Oct 2011 | €41M |
Top deals
largest disclosed rounds in H2 2011| Company | Stage | Date | Amount |
|---|---|---|---|
| Biocartis | Series C | Nov 2011 | €71M |
| AFFiRiS | Growth/Late | Nov 2011 | €25M |
| Sphere Medical Holding | Growth/Late | Oct 2011 | €18M |
| Orphazyme | Series A | Sep 2011 | €14M |
| uTest_Vamsi | Series D+ | Dec 2011 | €13M |
| MyoPowers Medical Technologies | Series B | Jul 2011 | €11M |
| Sapiens | Early VC | Nov 2011 | €10M |
| Aleva Neurotherapeutics | Series A | Aug 2011 | €9.5M |
| Miracor Medical Systems | Series B | Oct 2011 | €7.4M |
| Phagenesis | Other | Oct 2011 | €7.0M |
| Numares | Early VC | Oct 2011 | €7.0M |
| Autifony Therapeutics | Other | Aug 2011 | €7.0M |
| Veryan Medical | Other | Oct 2011 | €5.8M |
| AccuNostics | Early VC | Sep 2011 | €4.5M |
| Medlumics | Other | Dec 2011 | €3.5M |
Top investors
most active in H2 2011, by deal count- KFW2 deals
- Aescap1 deals
- Artemis1 deals
- Austria Wirtschaftsservice1 deals
- Bayern Kapital1 deals
- Blue Ocean Ventures1 deals
- Caixa Capital Risc1 deals
- Creathor Venture1 deals
- Delta Partners1 deals
- Earlybird Venture Capital1 deals